Brought to you by 
Cordis acquires AngioGuard
10 Aug 1999
Executive Summary
J&J's cardiology and electrophysiology company Cordis has acquired AngioGuard Inc. The private company has developed a containment technology that protects the heart and brain from embolic particles that can get dislodged during interventional surgery.
Deal Industry
-
Medical Devices
- Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Cordis acquires AngioGuard
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice